LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Ihre letzten Suchen

  1. AU="Barcelona, Laura"
  2. AU="McDonald, Bryan"
  3. AU="Martin, Jacqueline M"
  4. AU="Ingrisch, Doris"
  5. AU="Hanks, Ephraim M"
  6. AU="Ruiz-Narvaez, Edward A"
  7. AU="Krzysztof Kamiński"
  8. AU="Sharma, Ishna"
  9. AU="Warner, Brit"
  10. AU="JOCHEN SCHÖNGART"
  11. AU="Curdy, Nicolas"
  12. AU="Nkfusai, Claude Ngwayu"
  13. AU="Peng, Yonghan"
  14. AU="Decker, Miriam"
  15. AU="Campbell, Kerry"
  16. AU="Le Deley, Marie-Cécile" AU="Le Deley, Marie-Cécile"
  17. AU="Guan, Shu"

Suchergebnis

Treffer 1 - 10 von insgesamt 12

Suchoptionen

  1. Artikel ; Online: Análisis comparativo de las características clínicas, evolución y mortalidad de pacientes hospitalizados por COVID-19 durante la primera y segunda ola de la pandemia (Registro ECCOVID).

    Córdova, Ezequiel / Mykietiuk, Analia / De Vedia, Lautaro / Bacelar, Brenda / Cáceres, María Florencia / Nemirovsky, Corina / Contreras, Rosa / Alzogaray, Maria Fernanda / Nannini, Esteban / Consalvo, María Fernanda / Soler Puy, Lucrecia / Scapellato, Pablo G / Barcelona, Laura / Golikow, Mariana L / Piñeiro, María Florencia / Miño, Hugo J / Cabral, Myrna / Lamponi Tappata, Lucía / Lopardo, Gustavo /
    Sued, Omar / Stryjewski, Martín E

    Medicina

    2023  Band 83, Heft 4, Seite(n) 551–557

    Abstract: Introduction: Clinical features and outcomes of SARSCoV-2 infections may change between different waves of the pandemic. The objective of this study was to compare clinical characteristics and outcomes between two cohorts of patients hospitalized for ... ...

    Titelübersetzung Comparative analysis of clinical characteristics, evolution and mortality of hospitalized patients with COVID-19 during the first and second wave of the pandemic (ECCOVID Study).
    Abstract Introduction: Clinical features and outcomes of SARSCoV-2 infections may change between different waves of the pandemic. The objective of this study was to compare clinical characteristics and outcomes between two cohorts of patients hospitalized for COVID-19 during the first and second waves in Argentina.
    Methods: Multicenter and prospective registry of patients =18 years old with a confirmed diagnosis of COVID-19 admitted to 18 hospitals in Argentina during the first wave (March to October 2020) and second wave (March to July 2021) of the pandemic. Demographics, clinical characteristics, and outcomes of these patients were compared.
    Results: A total of 1691 patients were included (first wave n = 809, second wave n = 882). Hospitalized patients during the second wave were older (median 53 years vs. 61 years, p < 0.001), had more comorbidities (71% vs. 77%, p=0.007) and required more supplemental oxygen at admission (21% vs 62%, p < 0.001). During hospitalization, patients of the second wave required more supplemental oxygen (49% vs. 85%, p < 0.001), invasive ventilation (12% vs. 22%, p < 0.001) and had higher 30- day mortality (11% vs. 26%, p < 0.001). Comparing only patients who required supplemental oxygen during hospitalization, 30-day mortality was 20% and 30% p < 0.001 for the first and second wave, respectively.
    Conclusion: Compared to patients admitted during the first wave, patients admitted with SARS-CoV2 during the second wave in Argentina were more seriously ill and had a higher mortality.
    Mesh-Begriff(e) Humans ; Adolescent ; COVID-19 ; Pandemics ; RNA, Viral ; SARS-CoV-2 ; Oxygen ; Retrospective Studies
    Chemische Substanzen RNA, Viral ; Oxygen (S88TT14065)
    Sprache Spanisch
    Erscheinungsdatum 2023-08-15
    Erscheinungsland Argentina
    Dokumenttyp Multicenter Study ; English Abstract ; Journal Article
    ZDB-ID 411586-7
    ISSN 1669-9106 ; 0025-7680 ; 0325-951X
    ISSN (online) 1669-9106
    ISSN 0025-7680 ; 0325-951X
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Buch ; Artikel ; Online: Antimicrobial stewardship program in a developing country

    Lopardo, Gustavo / Titanti, Paola / Berdiñas, Verónica / Barcelona, Laura

    the epidemiological barrier: [letter to the editor]

    2015  

    Schlagwörter Antibacterianos ; Resistência Microbiana a Medicamentos ; Controle de Medicamentos e Entorpecentes ; Prescrição Inadequada ; Argentina ; Infecção Hospitalar ; Países em Desenvolvimento ; Uso de Medicamentos ; Hospitais Urbanos ; Controle de Infecções ; Condutas na Prática dos Médicos ; Guias de Prática Clínica como Assunto ; Sociedades Médicas ; Sociedades Científicas
    Erscheinungsdatum 2015-08-25T14:55:32Z
    Dokumenttyp Buch ; Artikel ; Online
    Datenquelle BASE - Bielefeld Academic Search Engine (Lebenswissenschaftliche Auswahl)

    Zusatzmaterialien

    Kategorien

  3. Artikel ; Online: Recomendaciones intersociedades para diagnóstico, tratamiento y prevención de las infecciones por Clostridioides difficile.

    Barcán, Laura / Ducatenzeiler, Laura / Bangher, María Del Carmen / Barcelona, Laura / Cornistein, Wanda / Daciuk, Lucía / De Paula, Juan / Desse, Jaier / Dictar, Miguel / Fernández-Canigia, Liliana / Nacinovich, Fancisco / Scapellato, Pablo / Martínez, Jorge Víctor

    Medicina

    2020  Band 80 Suppl 1, Seite(n) 1–32

    Abstract: Clostridioides difficile infections (CDI) are among the leading causes of health care-associated infections. The epidemiology of CDI has undergone major changes in the last decade, showing an increase in incidence, severity, and rate of relapse. These ... ...

    Titelübersetzung Intersociety guidelines for diagnosis, treatment and prevention of Clostridioides difficile infections.
    Abstract Clostridioides difficile infections (CDI) are among the leading causes of health care-associated infections. The epidemiology of CDI has undergone major changes in the last decade, showing an increase in incidence, severity, and rate of relapse. These guidelines were developed by specialists from four scientific societies: Sociedad Argentina de Infectología (SADI), Sociedad Argentina de Gastroenterología (SAGE), Sociedad Argentina de Bacteriología, Micología y Parasitología Clínicas (SADEBAC) and Asociación de Enfermeras en Control de Infecciones (ADECI). The objective of these intersociety guidelines is to provide national recommendations on CDI diagnosis, treatment and prevention. The methodology used involved the systematic review of the bibliography available up to December 2018, which was performed by six groups formed ad hoc: Epidemiology, Diagnosis, Treatment, Fecal Microbiota Transplantation, Special Populations, and Infection Control. The conclusions were presented and discussed in meetings held by each individual group and plenary meetings. In this document, updated diagnosis algorithms, therapeutic options (including fecal microbiota transplant) for immunocompetent and immunocompromised patients are presented, as well as strategies for the control of C. difficile infection.
    Mesh-Begriff(e) Argentina ; Clinical Laboratory Techniques ; Clostridium Infections/diagnosis ; Clostridium Infections/prevention & control ; Clostridium Infections/therapy ; Humans ; Risk Factors ; Societies, Medical
    Sprache Spanisch
    Erscheinungsdatum 2020-01-18
    Erscheinungsland Argentina
    Dokumenttyp Journal Article ; Practice Guideline
    ZDB-ID 411586-7
    ISSN 1669-9106 ; 0025-7680 ; 0325-951X
    ISSN (online) 1669-9106
    ISSN 0025-7680 ; 0325-951X
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  4. Artikel ; Online: Antimicrobial stewardship program in a developing country: the epidemiological barrier.

    Lopardo, Gustavo / Titanti, Paola / Berdiñas, Verónica / Barcelona, Laura / Curcio, Daniel

    Revista panamericana de salud publica = Pan American journal of public health

    2012  Band 30, Heft 6, Seite(n) 667–668

    Mesh-Begriff(e) Anti-Bacterial Agents/therapeutic use ; Argentina/epidemiology ; Cross Infection/drug therapy ; Cross Infection/epidemiology ; Developing Countries ; Drug Resistance, Microbial ; Drug Utilization ; Drug and Narcotic Control/organization & administration ; Hospitals, Urban ; Humans ; Inappropriate Prescribing/prevention & control ; Infection Control ; Practice Guidelines as Topic ; Practice Patterns, Physicians' ; Societies, Medical ; Societies, Scientific
    Chemische Substanzen Anti-Bacterial Agents
    Sprache Englisch
    Erscheinungsdatum 2012-02-22
    Erscheinungsland United States
    Dokumenttyp Letter
    ZDB-ID 1376934-0
    ISSN 1680-5348 ; 1020-4989
    ISSN (online) 1680-5348
    ISSN 1020-4989
    DOI 10.1590/s1020-49892011001200029
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  5. Artikel: Betalactámicos con inhibidores de betalactamasas. Amoxicilina-sulbactam.

    Barcelona, Laura / Marín, Marcelo / Stamboulian, Daniel

    Medicina

    2008  Band 68, Heft 1, Seite(n) 65–74

    Abstract: Betalactamases production is one of the main bacterial resistance mechanisms to betalactam antibiotics. The use of bectalactamases inhibitors combined with betalactam antibiotics allows the inactivation of certain betalactamases produced by Gram positive, ...

    Titelübersetzung Betalactam antibiotics combined with bectalactamases inhibitors. Amoxicillin-sulbactam.
    Abstract Betalactamases production is one of the main bacterial resistance mechanisms to betalactam antibiotics. The use of bectalactamases inhibitors combined with betalactam antibiotics allows the inactivation of certain betalactamases produced by Gram positive, Gram negative and anaerobic organisms, and even by mycobacteria. Betalactamases inhibitors are an improved therapeutic alternative compared with the other betalactam since, in most cases, they cover a wider antimicrobial spectrum than their analogues. Betalactamases enzimatic activity is specifically directed to the betalactam ring hydrolisis, producing a compound without antibacterial activity. According to their genomic position within microorganisms, betalactamases can be either chromosomic or plasmidic. Currently there are three betalactamases inhibitors locally available: clavulanic acid, sulbactam and tazobactam. Of them, only sulbactam has an intrinsic antimicrobial activity against penicillin binding proteins. The clinical experience from over 20 years confirms that the combination of betalactam antibiotics is effective in the empirical initial treatment of respiratory, intraabdominal, urinary tract and gynecologic infections, including those of polymicrobial origin. In the specific case of amoxicillin-sulbactam, experiences have shown the effectiveness of the combination in the treatment of peritonsillar abscess, otitis media, sinusitis, community acquired pneumonia, acute exacerbation of chronic obstructive pulmonar disease (COPD), urinary tract infection and obstetric/gynecologic infections. The spectrum and pharmacologic properties of this combination makes it also an excellent option for the treatment of skin/soft tissue and intraabdominal infections.
    Mesh-Begriff(e) Amoxicillin/therapeutic use ; Anti-Bacterial Agents/therapeutic use ; Community-Acquired Infections ; Drug Resistance, Multiple, Bacterial ; Drug Therapy, Combination ; Enzyme Inhibitors/therapeutic use ; Gram-Negative Bacteria/drug effects ; Gram-Negative Bacteria/enzymology ; Gram-Positive Bacteria/drug effects ; Gram-Positive Bacteria/enzymology ; Humans ; Microbial Sensitivity Tests ; Penicillin Resistance/drug effects ; Pneumonia, Bacterial/drug therapy ; Pulmonary Disease, Chronic Obstructive/drug therapy ; Sulbactam/therapeutic use ; beta-Lactam Resistance/drug effects ; beta-Lactamase Inhibitors ; beta-Lactamases/biosynthesis ; beta-Lactams/therapeutic use
    Chemische Substanzen Anti-Bacterial Agents ; Enzyme Inhibitors ; beta-Lactamase Inhibitors ; beta-Lactams ; Amoxicillin (804826J2HU) ; beta-Lactamases (EC 3.5.2.6) ; Sulbactam (S4TF6I2330)
    Sprache Spanisch
    Erscheinungsdatum 2008
    Erscheinungsland Argentina
    Dokumenttyp English Abstract ; Journal Article ; Review
    ZDB-ID 411586-7
    ISSN 1669-9106 ; 0025-7680 ; 0325-951X
    ISSN (online) 1669-9106
    ISSN 0025-7680 ; 0325-951X
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  6. Artikel ; Online: Argentine Intersociety Consensus on Urinary Infection 2018-2019 - Part I.

    Nemirovsky, Corina / López Furst, María José / Pryluka, Daniel / De Vedia, Lautaro / Scapellato, Pablo / Colque, Angel / Barcelona, Laura / Desse, Javier / Caradonti, Matías / Varcasia, Daniel / Ipohorski, Gagriel / Votta, Roberto / Zylberman, Marcelo / Romani, Adriana / Valdez, Pascual / Penini, Magdalena / De Paulis, Adriana / Lucero, Celeste / Sandor, Andrés /
    Contreras, Rosita / Nannini, Esteban / Gañete, Marcelo / Ralli, Héctor / Lopardo, Gustavo / Mykietiuk, Analía / Aronson, Sandra

    Medicina

    2020  Band 80, Heft 3, Seite(n) 229–240

    Abstract: The Argentine Society of Infectious Diseases and other scientific societies have updated these recommendations based on data on urinary tract infections in adults obtained from a prospective multicenter study conducted in Argentina during 2016-2017. ... ...

    Titelübersetzung Consenso Argentino Intersociedades de Infección Urinaria 2018-2019 - Parte I.
    Abstract The Argentine Society of Infectious Diseases and other scientific societies have updated these recommendations based on data on urinary tract infections in adults obtained from a prospective multicenter study conducted in Argentina during 2016-2017. Asymptomatic bacteriuria should be treated only in pregnant women, who should also be systematically investigated; the antibiotics of choice are nitrofurantoin, amoxicillin, clavulanic/amoxicillin, cephalexin and trimethoprim-sulfamethoxazole. In procedures involving injury to the urinary tract with bleeding, it is recommended to request urine culture and, in the presence of bacteriuria, antimicrobial treatment according to sensitivity should be prescribed from immediately before up to 24 hours after the intervention. In women, cystitis can be treated with nitrofurantoin, cephalexin or fosfomycin, while trimethoprim-sulfamethoxazole and fluoroquinolones are not recommended; pyelonephritis can be treated with ciprofloxacin, cefixime or cephalexin in ambulatory women or ceftriaxone, cefazolin or amikacin in those who are hospitalized. In men, urinary tract infections are always considered complicated; nitrofurantoin or cephalexin are recommended for 7 days, alternatively fosfomycin should be given in a single dose. In men, ciprofloxacin, ceftriaxone or cefixime are suggested for pyelonephritis on ambulatory treatment whereas ceftriaxone or amikacin are recommended for hospitalized patients. Acute bacterial prostatitis can be treated with ceftriaxone or gentamicin. Fluoroquinolones were the choice treatment for chronic bacterial prostatitis until recently; they are no longer recommended due to the increasing resistance and recent concerns regarding the safety of these drugs; alternative antibiotics such as fosfomycin are to be considered.
    Mesh-Begriff(e) Anti-Infective Agents, Urinary/therapeutic use ; Argentina ; Consensus ; Cystitis/diagnosis ; Cystitis/drug therapy ; Female ; Humans ; Male ; Pregnancy ; Prospective Studies ; Prostatitis/diagnosis ; Prostatitis/drug therapy ; Pyelonephritis/diagnosis ; Pyelonephritis/drug therapy ; Urinary Tract Infections/diagnosis ; Urinary Tract Infections/drug therapy
    Chemische Substanzen Anti-Infective Agents, Urinary
    Sprache Spanisch
    Erscheinungsdatum 2020-05-13
    Erscheinungsland Argentina
    Dokumenttyp Journal Article ; Practice Guideline
    ZDB-ID 411586-7
    ISSN 1669-9106 ; 0025-7680 ; 0325-951X
    ISSN (online) 1669-9106
    ISSN 0025-7680 ; 0325-951X
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  7. Artikel ; Online: Consenso Argentino Intersociedades de Infección Urinaria 2018-2019 - Parte II.

    Nemirovsky, Corina / López Furst, María José / Pryluka, Daniel / De Vedia, Lautaro / Scapellato, Pablo / Colque, Angel / Barcelona, Laura / Desse, Javier / Caradonti, Matías / Varcasia, Daniel / Ipohorski, Gagriel / Votta, Roberto / Zylberman, Marcelo / Romani, Adriana / Valdez, Pascual / Amalfa, Flavia / Lucero, Celeste / Fernández Lausi, Adriana / Fernández Garces, Alejandro /
    Rodríguez, Claudia / Chattas, Ana / Farina, Javier / Clara, Liliana / Nuccetelli, Yanina

    Medicina

    2020  Band 80, Heft 3, Seite(n) 241–247

    Abstract: The second part of the Inter-Society Argentine Consensus on Urinary Tract Infection (UTI) includes the analysis of special situations. In patients with urinary catheter, urine culture should be requested only in the presence of UTI symptomatology, before ...

    Titelübersetzung Argentine Intersociety Consensus on Urinary Infection 2018-2019 - Part II.
    Abstract The second part of the Inter-Society Argentine Consensus on Urinary Tract Infection (UTI) includes the analysis of special situations. In patients with urinary catheter, urine culture should be requested only in the presence of UTI symptomatology, before instrumentation of the urinary tract, or as a post-transplant control. The antibiotics recommended for empirical treatment in patients without risk factors are third-generation cephalosporins or aminoglycosides. UTIs associated with stones are always considered complicated. In case of obstruction with urosepsis, an emergency drainage should be performed via a percutaneous nefrostomy or ureteral stenting. In patients with stents or ureteral prostheses, such as double J catheters, empirical treatment should be based on epidemiology, prior antibiotics, and clinical status. Before the extracorporeal lithotripsy procedure, bacteriuria should be investigated and antibiotic prophylaxis should be administered in case of positive result, according to the antibiogram. First generation cephalosporins or aminoglycosides are valid alternatives. The use of antibiotic prophylaxis with first-generation cephalosporins or aminoglycosides before percutaneous nephrolithotomy is recommended. Transrectal prostatic biopsy can be associated with infectious complications, such as UTI or acute prostatitis, mainly due to Escherichia coli or other enterobacteria. In patients without risk factors for multiresistant bacteria and negative urine culture, prophylaxis with intravenous amikacin or ceftriaxone is recommended. In patients with positive urine culture, prophylaxis will be performed according to the antibiogram, from 24 hours before to 24 hours post-procedure. For the targeted treatment of post-transrectal biopsy prostatitis, carbapenems for 3-4 weeks are the treatment of choice.
    Mesh-Begriff(e) Anti-Infective Agents, Urinary/therapeutic use ; Argentina ; Consensus ; Female ; Humans ; Lithotripsy/adverse effects ; Male ; Nephrolithiasis/complications ; Nephrolithotomy, Percutaneous/adverse effects ; Prostatitis/drug therapy ; Prostatitis/etiology ; Risk Factors ; Stents/adverse effects ; Urinary Catheters/adverse effects ; Urinary Tract Infections/drug therapy ; Urinary Tract Infections/etiology
    Chemische Substanzen Anti-Infective Agents, Urinary
    Sprache Spanisch
    Erscheinungsdatum 2020-05-13
    Erscheinungsland Argentina
    Dokumenttyp Journal Article ; Practice Guideline
    ZDB-ID 411586-7
    ISSN 1669-9106 ; 0025-7680 ; 0325-951X
    ISSN (online) 1669-9106
    ISSN 0025-7680 ; 0325-951X
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  8. Artikel ; Online: Indications of a new antibiotic in clinical practice: results of the tigecycline initial use registry.

    Curcio, Daniel / Fernández, Francisco / Cané, Alejandro / Barcelona, Laura / Stamboulian, Daniel

    The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases

    2008  Band 12, Heft 3, Seite(n) 198–201

    Abstract: Tigecycline is the first of a new class of antibiotics named glycylcyclines and it was approved for the treatment of complicated intra-abdominal infections and complicated skin and skin structure infections. Notwithstanding this, tigecycline's ... ...

    Abstract Tigecycline is the first of a new class of antibiotics named glycylcyclines and it was approved for the treatment of complicated intra-abdominal infections and complicated skin and skin structure infections. Notwithstanding this, tigecycline's pharmacological and microbiological profile which includes multidrug-resistant pathogens encourages physicians' use of the drug in other infections. We analyzed, during the first months after its launch, the tigecycline prescriptions for 113 patients in 12 institutions. Twenty-five patients (22%) received tigecycline for approved indications, and 88 (78%) for "off label" indications (56% with scientific support and 22% with limited or without any scientific support). The most frequent "off label" use was ventilator associated pneumonia (VAP) (63 patients). The etiology of infections was established in 105 patients (93%). MDR-Acinetobacter spp. was the microorganism most frequently isolated (50% of the cases). Overall, attending physicians reported clinical success in 86 of the 113 patients (76%). Our study shows that the "off label" use of tigecycline is frequent, especially in VAP. due to MDR-Acinetobacter spp., where the therapeutic options are limited (eg: colistin). Physicians must evaluate the benefits/risks of using this antibiotic for indications that lack rigorous scientific support.
    Mesh-Begriff(e) Abdominal Cavity/microbiology ; Acinetobacter Infections/drug therapy ; Adolescent ; Adult ; Aged ; Aged, 80 and over ; Anti-Bacterial Agents/therapeutic use ; Bacterial Infections/drug therapy ; Bacterial Infections/microbiology ; Drug Labeling ; Drug Resistance, Multiple, Bacterial ; Enterobacteriaceae Infections/drug therapy ; Female ; Humans ; Male ; Middle Aged ; Minocycline/analogs & derivatives ; Minocycline/therapeutic use ; Prospective Studies ; Skin Diseases, Bacterial/drug therapy ; Soft Tissue Infections/drug therapy ; Staphylococcal Infections/drug therapy ; Tigecycline ; Treatment Outcome ; Young Adult
    Chemische Substanzen Anti-Bacterial Agents ; Tigecycline (70JE2N95KR) ; Minocycline (FYY3R43WGO)
    Sprache Englisch
    Erscheinungsdatum 2008-08-27
    Erscheinungsland Brazil
    Dokumenttyp Journal Article ; Multicenter Study ; Research Support, Non-U.S. Gov't
    ZDB-ID 2041400-6
    ISSN 1678-4391 ; 1413-8670
    ISSN (online) 1678-4391
    ISSN 1413-8670
    DOI 10.1590/s1413-86702008000300007
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  9. Artikel ; Online: Clinical characteristics and outcomes of hospitalized patients with SARS-CoV-2 infection in a Latin American country: Results from the ECCOVID multicenter prospective study.

    Cordova, Ezequiel / Mykietiuk, Analia / Sued, Omar / De Vedia, Lautaro / Pacifico, Natalia / Garcia Hernandez, Matias H / Baeza, Natalia M / Garibaldi, Franco / Alzogaray, Maria Fernanda / Contreras, Rosa / Soler Puy, Lucrecia / Scapellato, Pablo G / Barcelona, Laura / Golikow, Mariana L / Piñeiro, Maria Florencia / Miño, Hugo J / Consalvo, Maria Fernanda / Nemirovsky, Corina / Sanchez, Marisa /
    Cabral, Myrna / Lamponi Tappata, Lucia / Blasco, Mariano / Ballivian, Jamile / Lopardo, Gustavo / Stryjewski, Martin E

    PloS one

    2021  Band 16, Heft 10, Seite(n) e0258260

    Abstract: Background: Clinical features and outcomes of SARS-CoV-2 infections diverge in different countries. The aim of this study was to describe clinical characteristics and outcomes in a cohort of patients hospitalized with SARS-CoV-2 in Argentina.: Methods! ...

    Abstract Background: Clinical features and outcomes of SARS-CoV-2 infections diverge in different countries. The aim of this study was to describe clinical characteristics and outcomes in a cohort of patients hospitalized with SARS-CoV-2 in Argentina.
    Methods: Multicenter prospective cohort study of ≥18 years-old patients with confirmed SARS-CoV-2 infection consecutively admitted to 19 hospitals in Argentina. Multivariable logistic regression models were used to identify variables associated with 30-day mortality and admission to intensive care unit (ICU).
    Results: A total of 809 patients were analyzed. Median age was 53 years, 56% were males and 71% had at least one comorbidity. The most common comorbidities were hypertension (32%), obesity (23%) and diabetes (17%). Disease severity at admission was classified as mild 25%, moderate 51%, severe 17%, and critical 7%. Almost half of patients (49%) required supplemental oxygen, 18% ICU, and 12% invasive ventilation. Overall, 30-day mortality was 11%. Factors independently associated with ICU admission were male gender (OR 1.81; 95%CI 1.16-2.81), hypertension (OR 3.21; 95%CI 2.08-4.95), obesity (OR 2.38; 95%CI 1.51-3.7), oxygen saturation ≤93% (OR 6.45; 95%CI 4.20-9.92) and lymphopenia (OR 3.21; 95%CI 2.08-4.95). Factors independently associated with 30-day mortality included age ≥60 years-old (OR 2.68; 95% CI 1.63-4.43), oxygen saturation ≤93% (OR 3.19; 95%CI 1.97-5.16) and lymphopenia (OR 2.65; 95%CI 1.64-4.27).
    Conclusions: This cohort validates crucial clinical data on patients hospitalized with SARS-CoV-2 in Argentina.
    Mesh-Begriff(e) Adult ; Age Factors ; Aged ; Argentina/epidemiology ; COVID-19/mortality ; COVID-19/therapy ; Female ; Hospital Mortality ; Hospitalization ; Humans ; Male ; Middle Aged ; Prospective Studies ; Risk Factors ; SARS-CoV-2 ; Sex Factors
    Sprache Englisch
    Erscheinungsdatum 2021-10-08
    Erscheinungsland United States
    Dokumenttyp Clinical Trial ; Journal Article ; Multicenter Study ; Research Support, Non-U.S. Gov't ; Validation Study
    ISSN 1932-6203
    ISSN (online) 1932-6203
    DOI 10.1371/journal.pone.0258260
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  10. Artikel ; Online: RBD-specific polyclonal F(ab´)

    Lopardo, Gustavo / Belloso, Waldo H / Nannini, Esteban / Colonna, Mariana / Sanguineti, Santiago / Zylberman, Vanesa / Muñoz, Luciana / Dobarro, Martín / Lebersztein, Gabriel / Farina, Javier / Vidiella, Gabriela / Bertetti, Anselmo / Crudo, Favio / Alzogaray, Maria Fernanda / Barcelona, Laura / Teijeiro, Ricardo / Lambert, Sandra / Scublinsky, Darío / Iacono, Marisa /
    Stanek, Vanina / Solari, Rubén / Cruz, Pablo / Casas, Marcelo Martín / Abusamra, Lorena / Luciardi, Héctor Lucas / Cremona, Alberto / Caruso, Diego / de Miguel, Bernardo / Lloret, Santiago Perez / Millán, Susana / Kilstein, Yael / Pereiro, Ana / Sued, Omar / Cahn, Pedro / Spatz, Linus / Goldbaum, Fernando

    EClinicalMedicine

    2021  Band 34, Seite(n) 100843

    Abstract: Background: passive immunotherapy is a therapeutic alternative for patients with COVID-19. Equine polyclonal antibodies (EpAbs) could represent a source of scalable neutralizing antibodies against SARS-CoV-2.: Methods: we conducted a double-blind, ... ...

    Abstract Background: passive immunotherapy is a therapeutic alternative for patients with COVID-19. Equine polyclonal antibodies (EpAbs) could represent a source of scalable neutralizing antibodies against SARS-CoV-2.
    Methods: we conducted a double-blind, randomized, placebo-controlled trial to assess efficacy and safety of EpAbs (INM005) in hospitalized adult patients with moderate and severe COVID-19 pneumonia in 19 hospitals of Argentina. Primary endpoint was improvement in at least two categories in WHO ordinal clinical scale at day 28 or hospital discharge (ClinicalTrials.gov number NCT04494984).
    Findings: between August 1st and October 26th, 2020, a total of 245 patients were enrolled. Enrolled patients were assigned to receive two blinded doses of INM005 (
    Interpretation: Albeit not having reached the primary endpoint, we found clinical improvement of hospitalized patients with SARS-CoV-2 pneumonia, particularly those with severe disease.
    Sprache Englisch
    Erscheinungsdatum 2021-04-11
    Erscheinungsland England
    Dokumenttyp Journal Article
    ISSN 2589-5370
    ISSN (online) 2589-5370
    DOI 10.1016/j.eclinm.2021.100843
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang